Discussion This study has provided evidence regarding the utilization of GLP-1 RAs, including medications such as liraglutide and semaglutide, at various dosages within real-world settings
Consequently, it is not available on the NHS, nor is it accessible through licensed private prescribing channels in the UK
compounding pharmacies and a clinical team that, when the genetic test is included, reviews the patient's GLP1R, FTO, MC4R, GIPR, and TCF7L2 variants before titration a stratification step Sprout does not currently offer
This vascular mechanism may help explain why GLP-1RAs consistently show reduced dementia incidence in large observational cohorts, even when effects on amyloid burden or short-term cognition are modest [13,14,15]